Receptor Proteins for Nongenomic Actions of Thyroid Hormone

Author(s): Paul J. Davis, Jack L. Leonard, Hung-Yun Lin, Sandra Incerpi, Mary K. Luidens, Heng-Yuan Tang, Shaker A. Mousa

Journal Name: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization)
Formerly Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents

Volume 15 , Issue 1 , 2015


Genomic actions of thyroid hormone require the intranuclear binding by nuclear thyroid hormone receptors (TRs) of 3,5,3’-triiodo-L-thyronine (T3). Nongenomic actions of the hormone have been described that are initiated at the plasma membrane, in cytoplasm or in the mitochondrion. These are complex processes associated with maintenance of the cytoskeleton, control of cell respiration, cell proliferation—including tumor cell proliferation and angiogenesis—and nervous system function. We briefly review here the nature of the proteins which are now appreciated to initiate nongenomic actions of the hormone when they bind T3 or L-thyroxine (T4). These receptor proteins for nongenomic effects include truncated isoforms of TR

Keywords: Integrin α, μ-Crystallin, p28 TR, p43 TR, Pyruvate kinase M1, TR, TR, TRΔ

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 10 July, 2015
Page: [94 - 97]
Pages: 4
DOI: 10.2174/187152221501150710133309

Article Metrics

PDF: 28